Why the study?
Does increased epicardial adipose tissue (EAT) volume measured by CMR predict the diagnosis and prognosis of HFpEF?
Does increased epicardial adipose tissue (EAT) volume measured by CMR predict the diagnosis and prognosis of HFpEF?
Increased epicardial adipose tissue volume measured by CMR may serve as a valuable biomarker for the early diagnosis and prognosis of HFpEF.
Answers are grounded in this paper and cite their sources.
Supports EAT volume on CMR as HFpEF biomarker; hypothesis-generating pending prospective validation.
• Increased EAT volume as a potential biomarker for early diagnosis and prognosis of HFpEF. • CMR is highlighted as an effective tool for precisely measuring EAT volume, providing valuable insights for the assessment of HFpEF. • Higher EAT volumes are associated with a greater risk of HFpEF and MACE.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: